#Sparkling Sciences #TOMO YUME Group #iPSC Exosome

Sparkling Sciences Achieves INCI Certification for iPSC Exosome in Global Market

Sparkling Sciences Achieves INCI Certification for iPSC Exosome

Sparkling Sciences Co., Ltd., part of the TOMO YUME Group, recently announced the receipt of international INCI certification for its human mesenchymal stem cell-derived induced pluripotent stem cell (iPSC) exosomes. This prestigious certification recognizes the significance of iPSC exosomes in diverse applications, particularly in high-performance skincare, regenerative science research, and advanced biotechnology initiatives.

What is iPSC Technology?

Induced Pluripotent Stem Cell technology represents a breakthrough in regenerative medicine. Through innovative cellular reprogramming techniques, scientists can revert somatic cells back to a pluripotent state. This state allows the cells to differentiate into various cell types, thus establishing a crucial foundation for advances in regenerative medicine and life science.

Strategic Partnership with Kyoto University

In conjunction with this certification, Sparkling Sciences has successfully established a patent licensing agreement with Kyoto University, enhancing their capabilities in the production and application of iPSC exosomes. The collaboration underscores Sparkling Sciences' dedication to building a robust platform that includes cell culture, exosome isolation, purification, and quality management processes, enabling commercial-scale production of these innovative bioactive compounds.

The INCI certification is not just a symbol of compliance; it is indicative of Sparkling Sciences' comprehensive iPSC technology platform, which integrates mesenchymal stem cell (MSC) technology into the development of next-generation bioactive ingredients. The company is poised to set a new benchmark in global market positioning.